Glutamate Inhibitors in Glioblastoma

NCT05664464 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma

Interventions

DRUG: Gabapentin
DRUG: Sulfasalazine
DRUG: Memantine
DRUG: Temozolomide
RADIATION: Radiotherapy

Sponsor

University of Zurich

Collaborators

[object Object]